Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.

Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Doyle A, Ancell K, Panageas KS, Bluth M, Hedvat C, Erinjeri J, Ambrosini G, Marr B, Abramson DH, Dickson MA, Wolchok JD, Chapman PB, Schwartz GK
JAMA. 2014 311 (23): 2397-405

PMID: 24938562 · PMCID: PMC4249701 · DOI:10.1001/jama.2014.6096

MeSH Terms (16)

Adult Aged Aged, 80 and over Antineoplastic Agents, Alkylating Benzimidazoles Dacarbazine Disease Progression Female Humans Male Melanoma Middle Aged Survival Analysis Temozolomide Treatment Outcome Uveal Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: